Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month

ImmunityBio (NASDAQ:IBRX), an immunity-focused biotech, closed Friday’s session at $6.45, down 12.13%. The stock is still up 63.29% in the past five days and 207.14% in the past month. Trading volume reached 74.6 million shares, coming in about 238% above its three-month average of 22.1 million shares. ImmunityBio IPO'd in 2015 and has fallen 83% since going public. How the markets moved today The broader markets were relatively steady Friday, with the S&P 500 (SNPINDEX:^GSPC) edging up 0.03% to 6,915 a ...